DK1765844T3 - Purin-nukleotidderivater - Google Patents
Purin-nukleotidderivaterInfo
- Publication number
- DK1765844T3 DK1765844T3 DK05755520.3T DK05755520T DK1765844T3 DK 1765844 T3 DK1765844 T3 DK 1765844T3 DK 05755520 T DK05755520 T DK 05755520T DK 1765844 T3 DK1765844 T3 DK 1765844T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleotide derivatives
- purine nucleotide
- purine
- derivatives
- nucleotide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0413726.1A GB0413726D0 (en) | 2004-06-18 | 2004-06-18 | Compounds |
PCT/GB2005/002418 WO2005123755A2 (en) | 2004-06-18 | 2005-06-20 | Purine nucleotide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1765844T3 true DK1765844T3 (da) | 2014-09-01 |
Family
ID=32750205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05755520.3T DK1765844T3 (da) | 2004-06-18 | 2005-06-20 | Purin-nukleotidderivater |
Country Status (10)
Country | Link |
---|---|
US (1) | US8153609B2 (da) |
EP (1) | EP1765844B1 (da) |
JP (1) | JP5044750B2 (da) |
CN (1) | CN101001865A (da) |
AU (1) | AU2005254790B2 (da) |
CA (1) | CA2568907C (da) |
DK (1) | DK1765844T3 (da) |
ES (1) | ES2496946T3 (da) |
GB (1) | GB0413726D0 (da) |
WO (1) | WO2005123755A2 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007006544A2 (en) * | 2005-07-12 | 2007-01-18 | Vrije Universiteit Brussel | Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders |
GB0618235D0 (en) * | 2006-09-15 | 2006-10-25 | Lauras As | Process |
DK2448968T3 (da) * | 2009-06-29 | 2021-04-12 | Bioarctic Ab | ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER |
BR112013005872A2 (pt) | 2010-09-22 | 2019-09-24 | Alios Biopharma Inc | compostos, composição farmacêutica e respectivos usos |
AU2011349278C1 (en) * | 2010-12-22 | 2017-01-19 | Alios Biopharma, Inc. | Cyclic nucleotide analogs |
WO2013096680A1 (en) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
UA117095C2 (uk) | 2011-12-22 | 2018-06-25 | Аліос Біофарма, Інк. | Нуклеозидна сполука або її фармацевтично прийнятна сіль |
USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
NZ631601A (en) | 2012-03-21 | 2016-06-24 | Alios Biopharma Inc | Solid forms of a thiophosphoramidate nucleotide prodrug |
US9012427B2 (en) | 2012-03-22 | 2015-04-21 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
WO2022216577A1 (en) * | 2021-04-09 | 2022-10-13 | Merck Sharp & Dohme Llc | Novel forms of cyclic dinucleotide compounds |
WO2023031481A1 (en) | 2021-09-06 | 2023-03-09 | Mireca Medicines Gmbh | Improved methods for production of cyclic guanosine-monophosphate analogues |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3968101A (en) | 1974-12-20 | 1976-07-06 | Icn Pharmaceuticals, Inc. | 8-Substituted cyclic nucleotides by free radical alkylation and acylation |
WO1989007108A1 (en) * | 1988-02-01 | 1989-08-10 | Bernd Jastorff | Process for producing nucleoside-3',5'-cyclophosphates and nucleoside-3',5'-cyclothiophosphates |
AU4226693A (en) | 1992-05-01 | 1993-11-29 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Phosphorothioate derivatives of cyclic AMP analogues |
US5625056A (en) * | 1992-05-26 | 1997-04-29 | Biolog Life Science Institute | Derivatives of cyclic guanosine-3',5'-monophosphorothioate |
NO971997D0 (no) | 1997-04-29 | 1997-04-29 | Kjetil Tasken | Bruk av immunmodulerende midler |
CA2488611C (en) * | 2002-06-07 | 2011-11-15 | Kylix, B.V. | Compounds for modulating the activity of exchange proteins directly activated by camp (epacs) |
-
2004
- 2004-06-18 GB GBGB0413726.1A patent/GB0413726D0/en not_active Ceased
-
2005
- 2005-06-20 ES ES05755520.3T patent/ES2496946T3/es active Active
- 2005-06-20 US US11/629,908 patent/US8153609B2/en not_active Expired - Fee Related
- 2005-06-20 WO PCT/GB2005/002418 patent/WO2005123755A2/en active Application Filing
- 2005-06-20 AU AU2005254790A patent/AU2005254790B2/en not_active Ceased
- 2005-06-20 JP JP2007516050A patent/JP5044750B2/ja not_active Expired - Fee Related
- 2005-06-20 CA CA2568907A patent/CA2568907C/en not_active Expired - Fee Related
- 2005-06-20 DK DK05755520.3T patent/DK1765844T3/da active
- 2005-06-20 EP EP05755520.3A patent/EP1765844B1/en active Active
- 2005-06-20 CN CNA2005800259528A patent/CN101001865A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2496946T3 (es) | 2014-09-22 |
JP2008502673A (ja) | 2008-01-31 |
WO2005123755A3 (en) | 2006-04-06 |
EP1765844B1 (en) | 2014-07-30 |
AU2005254790B2 (en) | 2012-02-23 |
US8153609B2 (en) | 2012-04-10 |
WO2005123755A2 (en) | 2005-12-29 |
JP5044750B2 (ja) | 2012-10-10 |
EP1765844A2 (en) | 2007-03-28 |
CA2568907A1 (en) | 2005-12-29 |
CN101001865A (zh) | 2007-07-18 |
GB0413726D0 (en) | 2004-07-21 |
AU2005254790A1 (en) | 2005-12-29 |
US20080293665A1 (en) | 2008-11-27 |
CA2568907C (en) | 2015-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20161521L (no) | Antivirale forbindelser | |
DK1765844T3 (da) | Purin-nukleotidderivater | |
CY2016052I1 (el) | Τροποποιημενα φθοριομενα αναλογα νουκλεοζιδιων | |
NL1031741A1 (nl) | Purinederivaten. | |
ATE512960T1 (de) | Pyrimidinderivate | |
DK1778702T3 (da) | Antivirale forbindelser | |
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
MA28824B1 (fr) | Derives de pyrimidine | |
DK1725553T3 (da) | Tetrahydropyridoindolderivater | |
ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
NL2000323A1 (nl) | Pyrimidine-derivaten. | |
BRPI0718796A2 (pt) | Nucleotídeo | |
DE502005010369D1 (de) | Nockenwellenversteller | |
DE602005021995D1 (de) | Tintenstrahldrucker | |
ATE556080T1 (de) | Purinderivat | |
DE602005026472D1 (de) | Tintenstrahldrucker | |
DK1836211T3 (da) | Makrolider | |
ATE487718T1 (de) | Substituierte bizyklische pyrimidonderivate | |
DE602006010581D1 (de) | 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate | |
ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
DE502005011305D1 (de) | Nockenwellenversteller | |
DK1971588T3 (da) | Tiglien-3-onderivater |